Javascript must be enabled to continue!
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
View through CrossRef
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-fos Ab2, the other is to use microscopic cancer slides. These two methods were originally introduced by Prof. Omura of New York. The former is sensitive but not specific and the latter is not so sensitive but is specific. It is useful to investigate the diagnostic sensitivity of the microscopic cancer slide and the specificity of it to the type and differentiation of the cancer in order to utilize them to detect the presence of cancer tissue in clinical medicine.
Methods and Materials:
78 patients, made diagnosis of cancer, (gastric cancer: 30, colon cancer: 22, hepatocellular carcinoma (HCC): 5, Gall Bladder carcinoma: 1, Cholangiocarcinoma: 2, Pancreas carcinoma: 7, Breast cancer: 11) were analyzed. The cancer slides used were as follows.
Table 1
Used slides to detect the Cancer
Disease
Cancer slide
Gastric cancer
Tubular adenoca. / Poorly diff. Adenoca. / Signet-ring cell ca.
Colon cancer
Well diff. Adenoca./ Mucinous ca.
Hepatocellularr cancer
Moderately diff. adenoca.
GB & Cholangiocarcinoma
Well diff. adenoca.
Pancreas cancer
Tubular adenoca.
Breast cancer
Papillolubular ca. (A)(B)/ Solid-tubular ca./ Schirrous ca.
All malignant disease
Malignant lymphoma B-cell type of Colon
Result:
Diagnostic rates were as follows.
Table 2
Diagnostic rate of the Cancer by corresponding cancer slides
Disease
Diagnostic rate of each slide
Gastric cancer
Tubular adeno ca.
Poorly diff. Adeno ca.
Signet-ring cell ca.
66.7%
66.7%
66.7%
Colon cancer
Well diff. Adeno ca.
Mucinous ca.
95.7%
4.3%
Hepatocellar carcinoma
Moderately diff. adenoca.
100.0%
GB & Cholangiocarcinoma
Well diff. adenoca.
100.0%
Pancreas cancer
Tubular adenoca.
100.0%
Breast cancer
Papillotubular ca. (A)
Papillotubular ca. (B)
Solid-tubular ca.
Schirrous ca.
45.5%
72.7%
54.5%
63.6%
Table 3
No. of cancer resonance test positive slides
No response
1 slide
2 slides
3 slides
4 slides
Gastric Ca.
0(0.0%)
8(26.7%)
14(46.7%)
8(26.7%)
Colorectal Ca.
0(0.0%)
22(95.7%)
14.3(4.3%)
Hepatocellar carcinoma
0(0.0%)
5(100%)
GB&BD Ca.
0(0.0%)
3(100%)
Pancreas Ca.
0(0 0%)
3(100%)
Breast Ca.
0(0.0%)
4(36.4%)
2(18 2%)
3(27.3%)
2(18.2%)
To make diagnosis of cancer completely (100%), gastric cancer needed 3 slides, colon cancer did 2 slides, Hepatoceller, GB & Cholangiocarcinoma, and Pancreas cancer did only 1 slide, and breast cancer did 4 slides.
Table 4
Diagnostic rate of the Cancer by B-cell Malignant lymphoma slide
Disease
No. of Pt.
Rate (%)
Gastric cancer
30
100
Colon cancer
22
93.4
Hepatocellular cancer
5
100
GB & Cholangiocarcinoma
1/2
100
Pancreas cancer
7
100
Breast cancer
11
100
Discussion:
There was no correlation between the cancer tissue type, differentiation and tissue type of microscopic cancer slides. To make diagnosis of the cancer with the microscopic slides, several samples should be added by repeating the examination with trial and error, because of the specificity of resonance cannot be obvious. Diagnostic rate of the Cancer by B-cell Malignant lymphoma slide is very high but isn’t reach 100%. It is useful to screen cancer, because the response has less effect of tissue volume or concentration, different from chemical agent like Integrin α5β1 or Oncogene C-fos Ab2. Further examination is needed to make diagnostic rate to 100%, utilizing T-cell Malignant lymphoma slide or others.
Title: Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Description:
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods.
One is to use a chemical agent like Integrin α5β1 or Oncogene C-fos Ab2, the other is to use microscopic cancer slides.
These two methods were originally introduced by Prof.
Omura of New York.
The former is sensitive but not specific and the latter is not so sensitive but is specific.
It is useful to investigate the diagnostic sensitivity of the microscopic cancer slide and the specificity of it to the type and differentiation of the cancer in order to utilize them to detect the presence of cancer tissue in clinical medicine.
Methods and Materials:
78 patients, made diagnosis of cancer, (gastric cancer: 30, colon cancer: 22, hepatocellular carcinoma (HCC): 5, Gall Bladder carcinoma: 1, Cholangiocarcinoma: 2, Pancreas carcinoma: 7, Breast cancer: 11) were analyzed.
The cancer slides used were as follows.
Table 1
Used slides to detect the Cancer
Disease
Cancer slide
Gastric cancer
Tubular adenoca.
/ Poorly diff.
Adenoca.
/ Signet-ring cell ca.
Colon cancer
Well diff.
Adenoca.
/ Mucinous ca.
Hepatocellularr cancer
Moderately diff.
adenoca.
GB & Cholangiocarcinoma
Well diff.
adenoca.
Pancreas cancer
Tubular adenoca.
Breast cancer
Papillolubular ca.
(A)(B)/ Solid-tubular ca.
/ Schirrous ca.
All malignant disease
Malignant lymphoma B-cell type of Colon
Result:
Diagnostic rates were as follows.
Table 2
Diagnostic rate of the Cancer by corresponding cancer slides
Disease
Diagnostic rate of each slide
Gastric cancer
Tubular adeno ca.
Poorly diff.
Adeno ca.
Signet-ring cell ca.
66.
7%
66.
7%
66.
7%
Colon cancer
Well diff.
Adeno ca.
Mucinous ca.
95.
7%
4.
3%
Hepatocellar carcinoma
Moderately diff.
adenoca.
100.
0%
GB & Cholangiocarcinoma
Well diff.
adenoca.
100.
0%
Pancreas cancer
Tubular adenoca.
100.
0%
Breast cancer
Papillotubular ca.
(A)
Papillotubular ca.
(B)
Solid-tubular ca.
Schirrous ca.
45.
5%
72.
7%
54.
5%
63.
6%
Table 3
No.
of cancer resonance test positive slides
No response
1 slide
2 slides
3 slides
4 slides
Gastric Ca.
0(0.
0%)
8(26.
7%)
14(46.
7%)
8(26.
7%)
Colorectal Ca.
0(0.
0%)
22(95.
7%)
14.
3(4.
3%)
Hepatocellar carcinoma
0(0.
0%)
5(100%)
GB&BD Ca.
0(0.
0%)
3(100%)
Pancreas Ca.
0(0 0%)
3(100%)
Breast Ca.
0(0.
0%)
4(36.
4%)
2(18 2%)
3(27.
3%)
2(18.
2%)
To make diagnosis of cancer completely (100%), gastric cancer needed 3 slides, colon cancer did 2 slides, Hepatoceller, GB & Cholangiocarcinoma, and Pancreas cancer did only 1 slide, and breast cancer did 4 slides.
Table 4
Diagnostic rate of the Cancer by B-cell Malignant lymphoma slide
Disease
No.
of Pt.
Rate (%)
Gastric cancer
30
100
Colon cancer
22
93.
4
Hepatocellular cancer
5
100
GB & Cholangiocarcinoma
1/2
100
Pancreas cancer
7
100
Breast cancer
11
100
Discussion:
There was no correlation between the cancer tissue type, differentiation and tissue type of microscopic cancer slides.
To make diagnosis of the cancer with the microscopic slides, several samples should be added by repeating the examination with trial and error, because of the specificity of resonance cannot be obvious.
Diagnostic rate of the Cancer by B-cell Malignant lymphoma slide is very high but isn’t reach 100%.
It is useful to screen cancer, because the response has less effect of tissue volume or concentration, different from chemical agent like Integrin α5β1 or Oncogene C-fos Ab2.
Further examination is needed to make diagnostic rate to 100%, utilizing T-cell Malignant lymphoma slide or others.
Related Results
Cancer Metabolites Syndrome and Treatment for it.
Cancer Metabolites Syndrome and Treatment for it.
Concomitant with disappearance of reactions to Oncogene C-fos Ab2 and Integrin α5β1 detected by BDORT during treatment of patients with carcinoma, the general state of patients imp...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Abstract
Introduction
Fine-needle aspiration (FNA) is commonly used to investigate lymphadenopathy of suspected metastatic origin. The current study aims to find the association be...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
New Acupuncture Treatment Points of Cancer & Detecting Points of Cancer
New Acupuncture Treatment Points of Cancer & Detecting Points of Cancer
Introduction
By using electro-conductive wire from cancer reactive area, treatment point should be detective and acupuncture & moxibustion would be effectiv...
Submarine landslides in the Santa Barbara Channel as potential tsunami sources
Submarine landslides in the Santa Barbara Channel as potential tsunami sources
Abstract. Recent investigations using the Monterey Bay Aquarium Research Institutes (MBARI) Remotely Operated Vehicles (ROVs) "Ventana" and "Tiburon" and interpretation of MBARI's ...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract
Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...

